Drug
Povetacicept
Povetacicept: highest development phase Phase 3, developed by Vertex Pharmaceuticals. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Povetacicept NCT07890909 | Phase 3 | Immunoglobulin A Nephropathy |
| Povetacicept NCT07807995 | Phase 3 | Immunoglobulin A Nephropathy |
| Povetacicept NCT07204275 | Phase 2/3 | Primary Membranous Nephropathy |
| Povetacicept NCT07501702 | Phase 2 | Myasthenia Gravis, Generalized |
Latest
Follow Povetacicept on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.